Mapping the VF-14 Onto the EQ-5D-5L: The Potential to Estimate Quality-Adjusted Life-Years Without Generic Quality-of-Life Data in Ophthalmology

Author(s)

Ndwandwe S1, Ramsay AIG1, Fulop NJ1, Magnusson J1, Gandhi S1, Napier S2, Fu DJ3, Mills G1, Scully P1, Webster P4, Willson D1, Rufaeel I1, Symons A1, Khaw P5, Sivaprasad S5, Jayaram H5, Foster P5, Clarke C1
1University College London, London, UK, 2NIHR Moorfields Biomedical Research Centre--Patient Public Involvement Representative, London, UK, 3Moorfields Eye Hospital NHS FT, London, UK, 4Ubisense Ltd., Cambridge, UK, 5NIHR Moorfields Biomedical Research Centre at MEH NHS FT, London, UK

OBJECTIVES: The Visual Functioning-14 (VF-14) and EQ-5D-5L are two important questionnaires for estimating health-related quality of life. The EQ-5D-5L is widely recommended and used by regulatory bodies such National Institute for Health and Care Excellence (NICE) but not always collected. We have service evaluation data from patients who completed both questionnaires, and aim to develop a model mapping the VF-14 onto EQ-5D-5L scores for estimation of utility values for ophthalmology interventions in the UK.

METHODS: We will evaluate different modelling approaches—linear ordinary least squares (OLS), Tobit, censored least absolute deviation (CLAD), and major axis regression. Performance will be evaluated based on i) predictive ability using graphical plots, and root mean squared error (RMSE), mean absolute error (MAE), and Pearson and Spearman correlation coefficients; ii) goodness of fit using pseudo R2, AIC, and BIC. We will divide our dataset into two random samples—one for developing the model and the other for validation. We will explore sensitivity by mapping the VF-14 onto both the index and individual dimension responses.

RESULTS: We will identify the best performing model based on predictive ability and goodness of fit. We will also report the proportion of EQ-5D values that fall within the model’s 95% confidence interval. We will report properties of the regression datasets as the EQ-5D index has been shown to exhibit different characteristics such as ceiling effects and bimodal distribution.

CONCLUSIONS: We are not aware of UK studies that have mapped VF-14 scores on to EQ-5D utility scores. The closest study mapped ophthalmology-specific 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. We anticipate that the model can help regulators make better resource allocation decisions even in the absence of generic preference scores. Unlike previous studies that have predominantly used <500 data points, we have >3200 observations.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HTA250

Topic

Clinical Outcomes, Economic Evaluation

Topic Subcategory

Clinical Outcomes Assessment, Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Sensory System Disorders (Ear, Eye, Dental, Skin)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×